Given the similarity of the neuroinflammatory process and neuronal death-related pathology in AD and VaD, we raised the question of whether anti-TNF-α treatment can ameliorate memory impairments and microglia-based neuroinflammation in a VaD model. The gene discussed is TNF; the disease is memory impairment.